Jing Chen

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 4

Top Topics

Plasmodium Falciparum

Oxide Nanoparticles

Signaling Pathway

Top Venues

ACS applied materials & interfaces

Phytotherapy research : PTR

Biomedical chromatography : BMC

This page only lists publications with an associated author ORCID identifier.

Publications

Ming-Xuan Liu, Yu-Ting Cai, Ruo-Jia Wang, Peng-Fei Zhu, Yan-Chao Liu, Hao Sun, Yong Ling, Wei-Zhong Zhu, Jing Chen, Xiao-Ling Zhang
Aggregation-Induced Emission CN-Based Nanoparticles to Alleviate Hypoxic Liver Fibrosis via Triggering HSC Ferroptosis and Enhancing Photodynamic Therapy. ACS applied materials & interfaces (2024)
Ming-Xuan Liu, Yu-Ting Cai, Ruo-Jia Wang, Peng-Fei Zhu, Yan-Chao Liu, Hao Sun, Yong Ling, Wei-Zhong Zhu, Jing Chen, Xiao-Ling Zhang
Aggregation-Induced Emission CN-Based Nanoparticles to Alleviate Hypoxic Liver Fibrosis via Triggering HSC Ferroptosis and Enhancing Photodynamic Therapy. ACS applied materials & interfaces 16 (26) (2024)
Lirong Wang, Hongyan Ji, Shanhong Ni, Jinjing Xu, Yuanyuan Zhang, Xuesong Zhao, Xiuli Wu, Jingxuan Tian, Jing Chen
Antimalarial activity and sensitization of chrysosplenetin against artemisinin-resistant genotype Plasmodium berghei K173 potentially via dual-mechanism of maintaining host P-glycoprotein homeostasis mediated by NF-κB p52 or PXR/CAR signaling pathways and regulating heme/haemozoin metabolism. Phytotherapy research : PTR (2023)
Yisen Wang, Jingxuan Tian, Jie Chen, Shanhong Ni, Ying Yao, Lirong Wang, Xiuli Wu, Ruilong Song, Jing Chen
Non-targeted Metabolomics Intergrated with 1 H NMR and LC-Q-TOF-MS/MS Methods to Depict a More Comprehensive Metabolic Profile in Response to Chrysosplenetin and Artemisinin Co-Treatment against Artemisinin-Sensitive and -Resistant Plasmodium berghei K173. Biomedical chromatography : BMC (2022)